Gaithersburg - AstraZeneca
Introducing AstraZeneca's laboratory in Gaithersburg, USA, where innovative scientific research and ideas help to pioneer the next generation of medicines.
AstraZeneca expands US manufacturing footprint to accelerate …
2024年2月6日 · AstraZeneca is investing $300 million in a state-of-the-art facility in Rockville, MD to launch its life-saving cell therapy platforms in the US for critical cancer trials and future commercial supply.
AstraZeneca to Invest $300 Million in New Rockville Facility
2024年2月6日 · Governor Wes Moore announced today that AstraZeneca, a global science-led biopharmaceutical company which currently has a research lab at 1 Medimmune Way in Gaithersburg, will be investing $300 million in a new manufacturing facility at 9950 Medical Center Drive in Rockville.
AstraZeneca’s Cell Therapy Manufacturing Facility, Maryland, USA
2024年2月27日 · AstraZeneca, a biopharmaceutical company based in the UK, will build an advanced manufacturing facility in Rockville, Maryland, US, to launch its life-saving cell therapy platforms in the US, which are essential for critical cancer trials and future commercial supply.
AstraZeneca | Maryland Department of Commerce
BALTIMORE, MD (February 6, 2024) — Governor Wes Moore today announced that AstraZeneca, a global science-led biopharmaceutical company, is establishing a new manufacturing facility in Rockville. The company is investing $300 million in a state-of-the-art facility located at 9950 Medical Center Drive, where it will launch its life-saving cell ...
AstraZeneca plans state-of-the-art facility in Maryland
2024年2月6日 · Global biopharmaceutical company AstraZeneca is investing $300 million in a new state-of-the-art manufacturing facility in Montgomery County. The company will use the 84,000 square-foot location to launch its life-saving cell …
AstraZeneca Unveils New Cell Therapy Manufacturing Facility in Maryland
2024年2月7日 · AstraZeneca will be financially committing $300 million toward a state-of-the-art facility in Rockville, MD, a plant that will be responsible for creating cell therapy platforms in the United States for cancer trials, along with future commercial supply. 1
AstraZeneca expands US manufacturing footprint with $300 …
Wilmington, De., Feb. 6, 2024 – AstraZeneca is investing $300 million in a state-of-the-art facility in Rockville, Maryland to launch its life-saving cell therapy platforms in the US for critical cancer trials and future commercial supply. More than 150 new highly skilled jobs will be created to initially focus on manufacturing T-cell ...
Maryland Tech Council Applauds AstraZeneca’s Expansion in Maryland
Frederick, MD (February 6, 2024) – The Maryland Tech Council (MTC), the largest technology and life sciences trade association in the state, today commended AstraZeneca and the Moore Administration for the company’s newly announced manufacturing expansion in Maryland.
AstraZeneca brings its cell therapy ambitions to Maryland with …
2024年2月6日 · Tuesday, the British pharma announced it will plug $300 million into a new facility in Rockville, Maryland, to launch its cell therapy platforms in the U.S. for cancer trials and future...